GlassScriptPhysician profile
Kevin M Ford
NPI 1275608184
$1,707.84
in general payments reported to CMS, 2019-2025
17 companies · $23.40 in 2025
The $23.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,252 · 2020: $258 · 2022: $44.83 · 2023: $21.88 · 2024: $107 · 2025: $23.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $717.25 | 2019-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $327.93 | 2019-2022 | |
| Lilly USA, LLC | $172.16 | 2019-2020 | |
| Abbott Laboratories | $88.81 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $65.98 | 2019-2020 | |
| Pfizer INC. | $52.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.35 | 2019 | |
| Arbor Pharmaceuticals, INC. | $40.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.46 | 2019 | |
| Atricure, INC. | $24.67 | 2024 | |
| Abbvie INC. | $24.12 | 2019 | |
| Horizon Therapeutics Plc | $21.94 | 2020 | |
| Merck Sharp & Dohme LLC | $21.90 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.02 | 2019 | |
| Boston Scientific Corporation | $19.43 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $15.18 | 2020 | |
| Amarin Pharma, INC. | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.